FDA's Senior Advisor on Plain Language
Kathy Weil has been appointed as the Senior Advisor on Plain Language to lead the implementation of the Plain Writing Act throughout the agency. In this essential position, she is responsible for ensuring that FDA meets the mandates of the Act and that all employees have the training, tools, and resources to incorporate Plain Language Principles into their public communication. Ms. Weil leads the Plain Language Workgroup consisting of FDA employees whose contributions to implementing this Act are critical to its success. Her personal goal is to ensure that Plain Language Principles become an expected, integral, and sustainable part of FDA’s culture. Ms. Weil has worked at FDA since 2006 as an analyst, consumer safety officer, and branch chief. She holds a Bachelors in Nursing and Masters in Applied Communication, has practiced clinically, as a clinical research coordinator, and was both a medical writer and managing editor for a national medical publishing company.